BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 16382302)

  • 1. Metabolic control and educational status in children with type 1 diabetes: effects of a summer camp and intensive insulin treatment.
    Karagüzel G; Bircan I; Erişir S; Bundak R
    Acta Diabetol; 2005 Dec; 42(4):156-61. PubMed ID: 16382302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulin.
    Porcellati F; Rossetti P; Pampanelli S; Fanelli CG; Torlone E; Scionti L; Perriello G; Bolli GB
    Diabet Med; 2004 Nov; 21(11):1213-20. PubMed ID: 15498088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of breakfast and bedtime administration of insulin glargine in children and adolescents with Type 1 diabetes.
    Karagüzel G; Satilmiş A; Akçurin S; Bircan I
    Diabetes Res Clin Pract; 2006 Oct; 74(1):15-20. PubMed ID: 16621116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive replacement of basal insulin in patients with type 1 diabetes given rapid-acting insulin analog at mealtime: a 3-month comparison between administration of NPH insulin four times daily and glargine insulin at dinner or bedtime.
    Rossetti P; Pampanelli S; Fanelli C; Porcellati F; Costa E; Torlone E; Scionti L; Bolli GB
    Diabetes Care; 2003 May; 26(5):1490-6. PubMed ID: 12716810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin management and metabolic control of type 1 diabetes mellitus in childhood and adolescence in 18 countries. Hvidøre Study Group on Childhood Diabetes.
    Mortensen HB; Robertson KJ; Aanstoot HJ; Danne T; Holl RW; Hougaard P; Atchison JA; Chiarelli F; Daneman D; Dinesen B; Dorchy H; Garandeau P; Greene S; Hoey H; Kaprio EA; Kocova M; Martul P; Matsuura N; Schoenle EJ; Søvik O; Swift PG; Tsou RM; Vanelli M; Aman J
    Diabet Med; 1998 Sep; 15(9):752-9. PubMed ID: 9737804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood glucose levels in children with Type 1 diabetes attending a residential diabetes camp: a 2-year review.
    Carlson KT; Carlson GW; Tolbert L; Demma LJ
    Diabet Med; 2013 Mar; 30(3):e123-6. PubMed ID: 23157253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.
    Heller SR; Colagiuri S; Vaaler S; Wolffenbuttel BH; Koelendorf K; Friberg HH; Windfeld K; Lindholm A
    Diabet Med; 2004 Jul; 21(7):769-75. PubMed ID: 15209772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin requirements and metabolic control in children with diabetes mellitus attending a summer camp.
    Braatvedt GD; Mildenhall L; Patten C; Harris G
    Diabet Med; 1997 Mar; 14(3):258-61. PubMed ID: 9088776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy with insulin glargine (Lantus) in toddlers, children and adolescents with type 1 diabetes.
    Colino E; López-Capapé M; Golmayo L; Alvarez MA; Alonso M; Barrio R
    Diabetes Res Clin Pract; 2005 Oct; 70(1):1-7. PubMed ID: 16126116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
    Kanazawa Y; Igarashi Y; Komiya K; Sakurai Y; Shimizu T; Fujitani Y; Tanaka Y; Watada H; Kawamori R; Hirose T
    Endocr J; 2007 Dec; 54(6):975-83. PubMed ID: 18000343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
    Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003287. PubMed ID: 15495047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus.
    Siebenhofer A; Plank J; Berghold A; Narath M; Gfrerer R; Pieber TR
    Cochrane Database Syst Rev; 2004; (2):CD003287. PubMed ID: 15106199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glargine is superior to neutral protamine Hagedorn for improving glycated haemoglobin and fasting blood glucose levels during intensive insulin therapy.
    Fulcher GR; Gilbert RE; Yue DK
    Intern Med J; 2005 Sep; 35(9):536-42. PubMed ID: 16105155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of glycaemic control in patients with Type 1 diabetes commencing continuous subcutaneous insulin infusion therapy.
    Shalitin S; Gil M; Nimri R; de Vries L; Gavan MY; Phillip M
    Diabet Med; 2010 Mar; 27(3):339-47. PubMed ID: 20536498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized prospective study of insulin pump vs. insulin injection therapy in very young children with type 1 diabetes: 12-month glycemic, BMI, and neurocognitive outcomes.
    Nabhan ZM; Kreher NC; Greene DM; Eugster EA; Kronenberger W; DiMeglio LA
    Pediatr Diabetes; 2009 May; 10(3):202-8. PubMed ID: 19140899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additional lunchtime basal insulin during insulin lispro intensive therapy in a randomized, multicenter, crossover study in adults : a real-life design.
    Stades AM; Hoekstra JB; van den Tweel I; Erkelens DW; Holleman F;
    Diabetes Care; 2002 Apr; 25(4):712-7. PubMed ID: 11919130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of intensive mixture therapy with basal insulin therapy in insulin-naïve patients with type 2 diabetes receiving oral antidiabetes agents.
    Jacober SJ; Scism-Bacon JL; Zagar AJ
    Diabetes Obes Metab; 2006 Jul; 8(4):448-55. PubMed ID: 16776752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional intensified insulin therapy with short-acting insulin analog: effects on HbA1c and frequency of severe hypoglycemia. An observational cohort study.
    Hartemann-Heurtier A; Sachon C; Masseboeuf N; Corset E; Grimaldi A
    Diabetes Metab; 2003 Feb; 29(1):53-7. PubMed ID: 12629448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lunch and bedtime NPH insulin plus mealtime insulin Lispro therapy with premeal regular insulin plus bedtime NPH insulin therapy in type 2 diabetes.
    Sargin H; Sargin M; Altuntaş Y; Sengül AM; Orbay E; Seber S; Uçak S; Yayla A
    Diabetes Res Clin Pract; 2003 Nov; 62(2):79-86. PubMed ID: 14581144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.